Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Drug therapy; Montelukast; Pediatrics; Randomized controlled trial; GINA; Global Initiative for Asthma; EPR-3; Expert Panel Reports 3; JGCA; Japanese guideline for childhood asthma; ICS; inhaled corticosteroid; SpO2; oxygen saturation of periphera
مقالات ISI کورتیکواستروئیدهای استنشاقی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کورتیکواستروئیدهای استنشاقی; Adult asthma; Airway hyperresponsiveness; Asthma management; ICS; Step-down; Innate immunity; Regulatory T cell; IL-10; IL-33; ACh; Acetylcholine dichloride; Feno; Fractional exhaled nitric oxide; GINA; Global Initiative for Asthma; Hist; Histamine dihydr
Keywords: کورتیکواستروئیدهای استنشاقی; Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
Keywords: کورتیکواستروئیدهای استنشاقی; Obstructive airway disease; Clinical trial; Diet therapy; High-intensity interval training; ACQ; Asthma Control Questionnaire; AHR; airway hyperresponsiveness; AQLQ; Asthma-Related Quality-of-Life Questionnaire; Feno; fractional exhaled nitric oxide; GI;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Older adults; Elderly; Spirometry; Immunosenescence; Depression; Menopause; Education; Asthma COPD overlap syndrome; ACO; Asthma COPD overlap; CAM; Complementary and alternative medicine; COPD; Chronic obstructive pulmonary disease; HRT; Hormone r
Keywords: کورتیکواستروئیدهای استنشاقی; Neutrophils; phagocytosis; chronic obstructive pulmonary disease; Haemophilus species; exacerbations; CAT; COPD Assessment Test; cfDNA; Cell-free DNA; COPD; Chronic obstructive pulmonary disease; EN-RAGE; Ligand for the receptor for advanced glycation end
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; obesity; obese asthma; metabolic syndrome; microbiome; AHR; Airway hyperresponsiveness; BMI; Body mass index; CAMP; Childhood Asthma Management Program; ERV; Expiratory reserve volume; FVC; Forced vital capacity; ICS; Inhaled corticosteroid; ILC;
Keywords: کورتیکواستروئیدهای استنشاقی; COPD; chronic obstructive pulmonary disease; CVD; cardiovascular disease; DRS; disease risk score; ED; emergency department; ICD-9; International Classification of Diseases, Ninth Edition; ICS; inhaled corticosteroid; LABA; long-acting β2 agonist; LAMA;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Omalizumab; Medication adherence; Asthma exacerbation; Asthma control; CIU; Chronic idiopathic urticaria; COPD; Chronic obstructive pulmonary disease; ED; Emergency department; EXCELS; Evaluating Clinical Effectiveness and Long-term Safety in Pati
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma control; Conventional ICS; Extrafine beclometasone dipropionate; Extrafine ciclesonide; Extrafine-particle ICS; Fine-particle ICS; Inhaled corticosteroids; Observational studies; Real-life; BDP; Beclometasone dipropionate; CFC; Chlorofluorocarbon;
Keywords: کورتیکواستروئیدهای استنشاقی; Pharmacogenomics; gene expression; inhaled corticosteroids; apoptosis; system biology; CAMP; Childhood Asthma Management Program; DC; Differentially connected; DE; Differentially expressed; FEV1%; FEV1 percent of predicted; ICS; Inhaled corticosteroid; LC
Keywords: کورتیکواستروئیدهای استنشاقی; Disparities; socioeconomic status; education; psychological stress; asthma exacerbation; Vitamin D Add-On Therapy Enhances Corticosteroid trial; low income; BMI; Body mass index; ICS; Inhaled corticosteroid; SES; Socioeconomic status; VIDA; Vitamin D Add-
Keywords: کورتیکواستروئیدهای استنشاقی; asthma; critical care; pregnancy; primary medicine; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; ECCO2R; extracorporeal carbon dioxide removal; ECMO; extracorporeal membrane oxygenation; ICS; inhaled corticosteroid; IT; immunotherapy; LABA
Keywords: کورتیکواستروئیدهای استنشاقی; COPD; Budesonide; Formoterol fumarate dihydrate; Glycopyrronium; Co-suspension delivery technology; Pharmacokinetic; AE; adverse event; AUC0-â; area under the plasma concentration-time curve from time 0 to infinity; AUC0-12; area under the plasma
Keywords: کورتیکواستروئیدهای استنشاقی; Patient-reported outcomes; Health-related quality of life; Work and activity impairment; Asthma; Real-world; Fluticasone furoate/vilanterol; ACT; Asthma Control Test; ANCOVA; analysis of covariance; AQLQ (S); Standardized Asthma Quality of Life Questionna
Keywords: کورتیکواستروئیدهای استنشاقی; Inhaled drugs; Drug delivery; Pressurized metered-dose inhalers; Drug formulation; COPD; chronic obstructive pulmonary disease; DPI; dry powder inhaler; FDC; fixed-dose combination; HFA; hydrofluoroalkane; GOLD; Global Initiative for Chronic Obstructive L
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma guidelines; Agreement; Confidence; Adherence; Specialist; Primary care; National Asthma Survey; CHC; Community health center; EPR-3; Expert Panel Report 3; ICS; Inhaled corticosteroid; NAEPP; National Asthma Education and Prevention Program; NAMCS;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma exacerbation; asthma guidelines; Composite Asthma Severity Index; Seasonal Asthma Exacerbation Prediction Index; trajectories of lung growth; CASI; Composite Asthma Severity Index; COPD; Chronic obstructive pulmonary disease; EPR-3; Expert Panel Re
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; obesity; inhaled corticosteroid monotherapy; inhaled corticosteroid combination therapy; marginal structural Cox model; BMI; Body mass index; HFA-BDPeq; Hydrofluroalkane-propelled beclomethasone dipropionate or equivalent; HR; Hazard ratio; ICD-9/
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma severity; prevalence; population study; phenotypic diversity; ACT; Asthma Control Test; BMI; Body mass index; COPD; Chronic obstructive pulmonary disease; Feno; Fraction of exhaled nitric oxide; FVC; Forced vital capacity; ICS; Inhaled corticostero
Keywords: کورتیکواستروئیدهای استنشاقی; AFO; Animal feeding operation; AHR; Airway hyper-responsiveness; ATS; American thoracic society; BAL; Bronchoalveolar lavage; BAT; Best available technique; BPI; Bactericidal permeability-increasing; BREF; Reference document; CAFOs; Concentrated animal fe
Keywords: کورتیکواستروئیدهای استنشاقی; The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
Keywords: کورتیکواستروئیدهای استنشاقی; Oral corticosteroids; adverse effects; severe asthma; burst therapy; AE; Adverse effect; ICD-9; International Classification of Diseases, Ninth Edition; ICS; Inhaled corticosteroid; NCC; Number of chronic conditions (excluding asthma); OCS; Oral corticost
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; microbiome; neutrophil; eosinophil; ICS; Inhaled corticosteroid; OTU; Operational taxonomic unit; PERMANOVA; Permutational multiple ANOVA; qPCR; Quantitative PCR; SIMPER; Similarity of percentages;
Keywords: کورتیکواستروئیدهای استنشاقی; Pediatric; Summer camp; Allergy; Anaphylaxis; Asthma; Epinephrine autoinjector; Urgent care; Emergency care; EHR; Electronic health record; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; NHANES; National Health and Nutrition Examination Survey
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; children; inhaled corticosteroids; knemometry; urine cortisol excretion; FDA; US Food and Drug Administration; HPA; Hypothalamic-pituitary-adrenocortical; ICS; Inhaled corticosteroid; IQR; Interquartile range; LLGR; Lower-leg growth rate; pMDI; Pr
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma-chronic obstructive pulmonary disease overlap syndrome; Sinonasal inflammation; Lund-Mackay staging score; ACOS; Asthma-chronic obstructive pulmonary disease overlap syndrome; COPD; Chronic obstructive pulmonary disease; CT; Computed tomography; FE
Keywords: کورتیکواستروئیدهای استنشاقی; SMART; ICS/LABA; Symbicort Maintenance And Reliever Therapy; GINA; Asthma Control Test; ACT; Asthma Control Test; COPD; chronic obstructive pulmonary disease; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting inhaled β2-a
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Composite marker; Nitric oxide; Serum periostin; Type-2/eosinophilic inflammation; FeNO; fraction of exhaled nitric oxide; FEV1; forced expiratory volume in 1 s; ICS; inhaled corticosteroid; IgE; immunoglobulin E; IL; interleukin; iNOS; inducible
Keywords: کورتیکواستروئیدهای استنشاقی; bronchiectasis; inhaled antibiotics; inhaled corticosteroids; macrolides; aOR; adjusted OR; BRR; Bronchiectasis and NTM Research Registry; ICS; inhaled corticosteroid; LABA; long-acting beta agonists; NTM; nontuberculous mycobacteria; NTMir; NTM Info & Re
Keywords: کورتیکواستروئیدهای استنشاقی; Allergy; atopy; bronchiolitis; child; eczema; rhinovirus; respiratory syncytial virus; sensitization; virus; wheeze; wheezing; API; Asthma Predictive Index; ICS; Inhaled corticosteroid; OCS; Oral corticosteroid; OR; Odds ratio; RSV; Respiratory syncytial
Keywords: کورتیکواستروئیدهای استنشاقی; Severe asthma phenotypes; SARP; Endotype; Precision medicine; Biomarker; Cluster analysis; DREAM; Dose-Ranging Efficacy And safety with Mepolizumab; FeNO; Fractional excretion of nitric oxide; FEV1; Forced expiratory volume in 1 second; ICS; Inhaled corti
Keywords: کورتیکواستروئیدهای استنشاقی; Nonpharmacologic therapy; Bronchial thermoplasty; Pulmonary rehabilitation; Breathing techniques; AIR; Asthma Intervention Research; BT; Bronchial thermoplasty; BBT; Buteyko breathing technique; COPD; Chronic obstructive pulmonary disease; ED; Emergency d
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Pregnancy; Exacerbation; Macrophage; CD163; Inflammation; Eosinophil; Exhaled nitric oxide; BMI; Body mass index; CRP; C-reactive protein; Feno; Fractional exhaled nitric oxide; GWG; Gestational weight gain; ICS; Inhaled corticosteroid; OCS; Oral
Keywords: کورتیکواستروئیدهای استنشاقی; COPD; chronic obstructive pulmonary disease; ICS; inhaled corticosteroid; LABA; long-acting β2-agonist;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma Control Test; Asthma; Short-acting beta-agonist; Bronchodilator agents; Asthma exacerbation; Asthma rescue medication; ACT; Asthma Control Test; AUC; Area under the curve; ICS; Inhaled corticosteroid; MDI; Metered-dose inhaler; NPV; Negative predic
Keywords: کورتیکواستروئیدهای استنشاقی; Adrenaline; Allergen immunotherapy; Anaphylaxis; Epinephrine; Safety; Sublingual immunotherapy; Systemic allergic reaction; AE; Adverse event; AR/C; Allergic rhinitis with or without conjunctivitis; BAU; Bioequivalent allergen units; HDM; House dust mite;
Keywords: کورتیکواستروئیدهای استنشاقی; Eosinophils; biomarkers; severe eosinophilic asthma; DREAM; Dose Ranging Efficacy and safety With Mepolizumab in Severe Asthma; Feno; Fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; Inhaled corticosteroid; MENSA; Mepolizumab Adj
Keywords: کورتیکواستروئیدهای استنشاقی; ACOS; asthma-COPD overlap syndrome; BD; bronchodilation; CARAT; control of allergic rhinitis and asthma test; COPD; chronic obstructive pulmonary disease; FENO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1Â s; FVC; forced vital cap
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma flare; acute asthma; asthma attack; wheezing; acute asthma diagnosis; acute asthma management; COPD; Chronic obstructive pulmonary disease; EPR-3; Expert Panel Report 3; ICS; Inhaled corticosteroid; MDI; Metered-dose inhaler; NPPV; Noninvasive posi
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Control; Biologics; Eosinophilic asthma; Severe asthma; Uncontrolled asthma; DDP-4; dipeptidyl peptidase 4; Feno; fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting beta2 agonist; S
Keywords: کورتیکواستروئیدهای استنشاقی; Biologic therapy; Comorbidities; Adherence; Inhaled corticosteroid; Phenotype; Severe asthma; ABPA; Allergic bronchopulmonary aspergillosis; AERD; Aspirin-exacerbated respiratory disease; COPD; Chronic obstructive pulmonary disease; CRS; Chronic rhinosinu
Keywords: کورتیکواستروئیدهای استنشاقی; Childhood severe asthma; Difficult to treat asthma; Severe asthma phenotypes; Severe asthma treatment; Review; EPA; Environmental Protection Agency; ETS; Environmental tobacco smoke; FDA; Food and Drug Administration; ICS; Inhaled corticosteroid; LABA; Lo
Keywords: کورتیکواستروئیدهای استنشاقی; Adherence; Asthma; CMA; Inhaled corticosteroids; OPCRD; Pharmacoepidemiology; Cohort study; ICS; Inhaled corticosteroid; CMA; Continuous medication availability; OPCRD; Optimum Patient Care Research Database; ID; Index prescription date;
Keywords: کورتیکواستروئیدهای استنشاقی; Omalizumab; Allergic asthma; IgE; Meta-analysis; Effectiveness; ACT; Asthma Control Test; AQLQ; Asthma-related Quality-of-Life Questionnaire; FEV1; Forced expiratory volume in 1 second; GETE; Global Evaluation of Treatment Effectiveness scale; ICS; Inhale
Keywords: کورتیکواستروئیدهای استنشاقی; Severe asthma; Severe recurrent wheeze phenotypes; Children; Bacterial infection; Gastroesophageal reflux; Multiple allergies; BMI; Body mass index; FP; Fluticasone propionate; GERD; Gastroesophageal reflux; ICS; Inhaled corticosteroid; LTRA; Leukotriene
Keywords: کورتیکواستروئیدهای استنشاقی; Childhood asthma; Phenotype; Refractory asthma; Severe asthma; Gene expression; Corticosteroid; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; ICS; inhaled corticosteroid; PBMC; peripheral blood mononuclear cell; SABA; shor
Keywords: کورتیکواستروئیدهای استنشاقی; Allergy; asthma; IgE; omalizumab; pediatric; AA; Allergic asthma; AE; Adverse event; EMA; European Medicines Agency; EXCELS; Epidemiologic Study of Xolair (omalizumab): Evaluating Clinical Effectiveness and Long-term Safety in Patients with Moderate-to-Se
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Adult-onset; Late-onset; Cluster analysis; Phenotypes; Follow-up; Longitudinal; Smoking; Obesity; Early-onset; ACOS; Asthma-COPD overlap syndrome; ACT; Asthma control test; AQ20; Airways Questionnaire 20; BD; Bronchodilator; COPD; Chronic obstruct
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; sputum; inflammation; sensitization; inner city; ACT; Asthma Control Test; BMI; Body mass index; DTT; Dithiothreitol; Foxp3; Forkhead box p3; ICS; Inhaled corticosteroid; MFI; Median fluorescence intensity; Mini-AQLQ; Mini-Asthma Quality of Life Q